University of Michigan Regents Minutes October 2025
Equity Investment Approved with Enexa Bio Inc.
Trusted by teams at
Description
The Regents authorized equity investment agreements with Enexa Bio, Inc. through UM's Innovation Partnerships venture funds, amounting up to 10% of fund assets.
Contract Details
Contract Amount
Up to 10% of fund assets under management
Vendor
ENEXA BIO INC
Agency
University of Michigan Board of Regents, MI
Contract Type
FINANCIAL_SERVICES
Document Date
October 16, 2025
Renewal Info
Possible multiple investment rounds, up to 10% of total fund assets.
More from ENEXA BIO INC
Related Contracts
University of Michigan Board of Regents Minutes 2026-03-19
APPROVEDUniversity of Michigan Commercialization Agreements Nov 2025
APPROVEDMore from University of Michigan Board of Regents
University of Michigan Regents Communication Report March 2026
University of Michigan Regents Communication Report March 2026
University of Michigan Regents Communication Action Request March 2026
University of Michigan Regents Communication Report March 2026
University of Michigan Regents Communication Action Request March 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.